mercredi 19 octobre 2016

Onco Actu du 19 octobre 2016

1. Biologie

The evolution of lifespan and age-dependent cancer risk [The Evolution and Medicine Review]

Tasmanian devils developing immune response to contagious face cancer [The Guardian]

3.1 Tabac

Everything adolescents should know about the dangers of tobacco [Stanford Medicine]

3.1.1 Tabac - e-cigs

Eye doctors warn of e-cigarette liquid hazard [Reuters]

3.3 Prévention - Vaccins

Advocates push vaccines for boys amid rise in HPV-caused cancers [The Glode and Mail]

New Approach to Promoting HPV Vaccinations [Wall Street Journal]

5. Traitements

How a little known organ could protect people who’ve had stem cell transplants [Cancer Research UK]

5.12 Immunothérapies

Melanoma Immunotherapy Significantly Improved with Peptide Bath [GEN]

J&J eyes immuno-oncology with 15 R&D assets [FierceBiotech]

5.12.2 Immunothérapies - CAR-T

Kite CEO Arie Belldegrun preps for a looming date with the FDA as he tackles first-mover advantage in CAR-T [EndPoints]

5.2 Pharma

Bayer’s Euphoria Around New Cancer Medicine Meets Skepticism [Bloomberg]

5.2.1 Pharma - Partenariats

AstraZeneca backs ADC in $105M to support 6 clinical oncology candidates [FierceBiotech]

5.2.3 Pharma - économie

CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ Haul [Xconomy]

Gene editing loses its sizzle. CRISPR Therapeutics IPO debuts beneath the range [EndPoints]

5.3.4 Traitements - AMM (FDA, EMA)

Roche's Tecentriq scores lung cancer nod, setting up 3-way battle with Merck, BMS [FiercePharma]

FDA approves Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for people with a specific type of metastatic lung cancer [Roche]

EMA Adopts a New Indication for Nivolumab [ESMO]

Withdrawal of the Marketing Authorisation Application for Cediranib [ESMO]

Roche's lung cancer drug wins U.S. approval [Reuters]

5.4 Traitements - Economie

Treat pharma as a utility, and 10 other ways states can lower drug prices [STAT]

6. Lutte contre les cancers

New consent forms for cancer treatments published [Cancer Research UK]

6.1 Observation

Cancers Causing the Largest Loss of Healthy Life Years Associated with Major Preventable Risk Factors [ACS]

6.6 Publications

Evolved Metrics for the New Age of Research: Digital Science Webinar Summary [Digital Science]

6.7 DMP, Big Data & applis

IBM and Quest forge precision cancer treatment partnership [Pharmafile]

IBM and Quest forge precision cancer treatment partnership [Pharmafile]

6.7.2 Applis

Celgene partners to develop ResearchKit app for observational study [FierceBiotech]

6.8 Communication

Gerd Gigerenzer podcast: systematic misinformation of the public about health care [HealthNewsReview]